DENTSPLY SIRONA (NASDAQ:XRAY) Stock Rating Lowered by StockNews.com

DENTSPLY SIRONA (NASDAQ:XRAY) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Friday.

Other analysts have also issued research reports about the company. Needham & Company LLC decreased their price objective on DENTSPLY SIRONA from $42.00 to $36.00 and set a “buy” rating on the stock in a research note on Friday. Piper Sandler reaffirmed a “neutral” rating and set a $32.00 price target (down from $35.00) on shares of DENTSPLY SIRONA in a research note on Friday. Robert W. Baird cut their price objective on shares of DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating for the company in a research report on Friday. Barrington Research decreased their target price on shares of DENTSPLY SIRONA from $41.00 to $38.00 and set an “outperform” rating on the stock in a research report on Friday. Finally, Leerink Partnrs reissued an “outperform” rating on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. Five research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $36.90.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ XRAY traded down $0.09 on Friday, hitting $28.29. The company’s stock had a trading volume of 4,506,596 shares, compared to its average volume of 3,342,785. The stock has a 50 day moving average of $32.13 and a 200-day moving average of $32.71. The company has a market capitalization of $5.87 billion, a price-to-earnings ratio of -45.63, a price-to-earnings-growth ratio of 1.22 and a beta of 1.00. DENTSPLY SIRONA has a 12-month low of $26.27 and a 12-month high of $41.65. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.38 and a quick ratio of 0.95.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.42. The firm had revenue of $953.00 million for the quarter, compared to analyst estimates of $969.45 million. DENTSPLY SIRONA had a positive return on equity of 11.14% and a negative net margin of 3.33%. DENTSPLY SIRONA’s revenue was down 2.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.39 EPS. As a group, research analysts predict that DENTSPLY SIRONA will post 2.05 EPS for the current year.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. GSA Capital Partners LLP acquired a new stake in DENTSPLY SIRONA in the first quarter valued at $655,000. Central Pacific Bank Trust Division acquired a new stake in shares of DENTSPLY SIRONA in the 1st quarter valued at about $64,000. Financial Counselors Inc. lifted its position in shares of DENTSPLY SIRONA by 4.2% during the first quarter. Financial Counselors Inc. now owns 218,576 shares of the medical instruments supplier’s stock worth $7,255,000 after purchasing an additional 8,793 shares during the last quarter. FORA Capital LLC acquired a new position in DENTSPLY SIRONA in the first quarter worth about $771,000. Finally, Daiwa Securities Group Inc. increased its holdings in DENTSPLY SIRONA by 7.9% in the first quarter. Daiwa Securities Group Inc. now owns 17,652 shares of the medical instruments supplier’s stock valued at $585,000 after buying an additional 1,296 shares during the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.